CHRD - Chord Energy Corporation
Chord Energy is rated a buy, trading at 7.5x forward earnings with a 17.5% FCF yield and only 0.4x leverage. CHRD's XTO acquisition added superior acreage, positioned it as the Bakken's consolidator, and management signals more disciplined M&A ahead. Operational advances—four-mile laterals, AI-optimized lift, and improved decline rates—set up a 2027 production inflection without extra capital.
Does Chord Energy Corporation (CHRD) have what it takes to be a top stock pick for momentum investors? Let's find out.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
MaverickX announced today that it has closed a strategic capital round with Chord Energy and has secured additional investment from Olive Tree Capital.
PBI, CHRD, BTSG, MPC and LYB are showing relative price strength as Wall Street notches fresh highs.
Chord Energy is rated a Buy, driven by disciplined capital allocation, aggressive buybacks, and a conservative balance sheet. CHRD prioritizes free cash flow per share over production growth, leveraging long-lateral drilling and operational efficiencies to lower breakevens by $8-$12/barrel. Management has reduced share count by 12% since 2023, signaling conviction that the stock is undervalued at ~3x EV/EBITDA, well below peers.
Chord Energy remains undervalued despite a 40% share price increase, offering substantial value at normalized $70 WTI crude pricing. CHRD consistently generates over 20% free cash flow yields at current prices, driven by improved supply-demand dynamics in crude oil. The 4-mile well development program has unlocked 4% year-over-year production growth within a CAPEX budget set at $60 WTI.
Chord Energy Corporation (CHRD) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
The Amplify Energy & Natural Resources Covered Call ETF (NYSEARCA:NDIV) sells call options against a basket of energy and natural resources equities to convert commodity volatility into monthly cash distributions.
Chord Energy Q1 earnings beat estimates as higher oil production and stronger oil and natural gas price realizations support revenues and cash flow growth.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Sales-growth screen highlights CHRD, BAC and CHDN as buys as U.S. equities hit new highs despite tariffs, oil swings and sticky inflation.
Chord Energy Corporation (CHRD) Q1 2026 Earnings Call Transcript
Chord Energy Corporation (CHRD) came out with quarterly earnings of $4.56 per share, beating the Zacks Consensus Estimate of $3.35 per share. This compares to earnings of $4.04 per share a year ago.
HOUSTON, May 5, 2026 /PRNewswire/ -- Chord Energy Corporation (NASDAQ: CHRD) ("Chord," "Chord Energy," or the "Company") today reported financial and operating results for the first quarter 2026. Key Takeaways and Updates: Operational Strength: Cash Flow from Operations and Adjusted Free Cash Flow exceeded expectations in 1Q26, supported by oil volumes above the high-end of guidance and capital in line with expectations; Improving Efficiency: Strong drilling and completions ("D&C") and production operations led Chord to increase FY26 oil volumes by 2 MBopd to 161 MBopd while keeping capital unchanged; 4-Mile Lateral Update: Successfully executed and turned in line ("TIL") the Toonie 5-well pad, representing Chord's first full 4-mile DSU development.
SM is set to report Q1 earnings on May 6, with early-quarter oil-price swings anticipated to have pressured upstream profitability despite rising output.
ICU Medical's new high-volume pump has more connected features, which we believe will drive retention rates and incremental revenue. SiteOne Landscape Supply controls 18% of this $26 billion industry and has been growing revenue at a low double-digit compound annual growth rate over the past several years. Madison Small Cap Fund liquidated its position in Globus Medical after a multi-year period because the company's success drove its market cap to $12B.
Stocks like SANM, CHRD, MPC and CVE are seeing price strength and have a high chance of carrying the momentum forward.
Investors need to pay close attention to CHRD stock based on the movements in the options market lately.
Chord Energy Corporation (CHRD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.